Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      GSK lifts annual profit forecast after third quarter beat on vaccines strength

      GSK lifts annual profit forecast after third quarter beat on vaccines strength

      Medical Dialogues Bureau31 Oct 2019 9:00 AM IST
      GSK now expects full-year profit to be roughly flat compared to last year at constant currency, up from a previous forecast of a fall of 3% to 5%.New...
      IOL Chemicals and Pharma Ibuprofen manufacturing facilities in Barnala clears USFDA inspection

      IOL Chemicals and Pharma Ibuprofen manufacturing facilities in Barnala clears USFDA inspection

      Medical Dialogues Bureau30 Oct 2019 2:11 PM IST
      Mumbai: IOL Chemicals and Pharmaceuticals (IOLCP) recently received a communication from US Food and Drug Administration (USFDA) with respect to an...
      New tests shows NO sign of asbestos in recalled JnJ baby powder

      New tests shows NO sign of asbestos in recalled JnJ baby powder

      Medical Dialogues Bureau30 Oct 2019 1:18 PM IST
      But Johnson & Johnson (JnJ) said in a statement that dozens of tests by two outside firms did not detect any asbestos in JnJ's baby powder.New...
      Pfizer cancer drug Ibrance higher sales beat Q3 profit estimates

      Pfizer cancer drug Ibrance higher sales beat Q3 profit estimates

      Medical Dialogues Bureau30 Oct 2019 9:30 AM IST
      Pfizer said it expects to earn between $2.94 per share and $3.00 per share, up from a prior estimate of $2.76 to $2.86. Analysts on average were...
      Amgen Repatha to be available exclusively at 60 pc lower price in 2020

      Amgen Repatha to be available exclusively at 60 pc lower price in 2020

      Medical Dialogues Bureau30 Oct 2019 9:15 AM IST
      New Delhi: Amgen recently announced that effective Dec. 31, 2019, Repatha (evolocumab), an innovative treatment for patients with high cholesterol and...
      Jubilant Life Sciences appoints Alok Vaish as CFO, Key Managerial Personnel

      Jubilant Life Sciences appoints Alok Vaish as CFO, Key Managerial Personnel

      Medical Dialogues Bureau30 Oct 2019 9:00 AM IST
      New Delhi: Jubilant Life Sciences has recently announced its board has approved the appointment of Alok Vaish as Chief Financial Officer and Key...
      Alkem Labs Bioeguivalcnce Center at Taloja clears USFDA inspection

      Alkem Labs Bioeguivalcnce Center at Taloja clears USFDA inspection

      Medical Dialogues Bureau28 Oct 2019 10:00 AM IST
      "This is to inform that the US FDA had conducted an inspection at Alkem Laboratories Ltd's Bioequivalence Center located at Taloja, Maharashtra from...
      Piramal Enterprises plans to raise upto Rs 1000 crore via NCDs

      Piramal Enterprises plans to raise upto Rs 1000 crore via NCDs

      Medical Dialogues Bureau28 Oct 2019 9:45 AM IST
      The administrative committee of the board approved the issue of secured NCDs on private placement basis up to Rs 500 crore with an option to retain...
      Alembic Pharma international formulations grew 10pc to Rs 646 crore in Q2

      Alembic Pharma international formulations grew 10pc to Rs 646 crore in Q2

      Medical Dialogues Bureau28 Oct 2019 9:30 AM IST
      Alembic said its international formulations grew 10 per cent to Rs 646 crore in the quarter under review and 17 per cent to Rs 1,099 crore in the...
      Foamix Pharma wins USFDA nod for Amzeeq, topical minocycline treatment for acne

      Foamix Pharma wins USFDA nod for Amzeeq, topical minocycline treatment for acne

      Medical Dialogues Bureau28 Oct 2019 9:15 AM IST
      “The USFDA approval of AMZEEQ ((minocycline) topical foam, is a milestone moment in dermatology and the most significant advancement with minocycline...
      Alexion Pharma to acquire clinical-stage biopharmaceutical firm Achillion

      Alexion Pharma to acquire clinical-stage biopharmaceutical firm Achillion

      Medical Dialogues Bureau28 Oct 2019 9:00 AM IST
      New Delhi: Alexion Pharmaceuticals, Inc. and Achillion Pharmaceuticals, Inc. recently announced that they have entered into a definitive agreement...
      Jubilant Life gets ANDA final nod for Clomipramine Hydrochloride Capsules to treat OCD

      Jubilant Life gets ANDA final nod for Clomipramine Hydrochloride Capsules to treat OCD

      Medical Dialogues Bureau27 Oct 2019 10:00 AM IST
      New Delhi: Jubilant Life Sciences Ltd recently announced that Jubilant Pharma Limited, a material wholly-owned subsidiary of the Company, through one...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok